Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say - Reuters
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxNRXcwd2ZTOXFZNXBqRlU5ZERTQkVXYW1BZDFpZFpNOXVEdEk1V3pDUEdpa0FadURxcGYtMVNjRHRBSkxoWDdxcWtBcERNVUdaYkU1d1lCWlFMT1dkX3pHOVp1dnUtSko3aERhaDh5UElCd0RlcWpOQmIwNVdHbmJiUWQyZjNOQlY3QUhRWHV1N3h1QnFNdUhVemo2UkltZF9NeklhWjRmNWVuZ2ZfUEJ2Z2dmVnR3Z29N?oc=5" target="_blank">Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say</a> <font color="#6f6f6f">Reuters</font>
Dr Reddy's Laboratories plans to launch its generic semaglutide injection, potentially named Obeda, in India by March 2026, following the patent expiry of semaglutide. The company aims to price it competitively, potentially up to 60% below the branded product.
Dr Reddy's Laboratories has applied to trademark the brand name 'Obeda' for its upcoming generic version of semaglutide, the active ingredient in Novo Nordisk's Ozempic. The launch is anticipated in March 2026, coinciding with the patent expiry of semaglutide in India.
Similar Stories
Related coverage based on topic and tags
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value - Reuters
India's Dr Reddy's delays semaglutide supply, loses $678 mln in market value Reuters
July 9, 2026 at 04:54 AMIndia's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026 at 12:23 PMIndia's Sun Pharma wins South Africa approval to launch generic Ozempic - Reuters
India's Sun Pharma wins South Africa approval to launch generic Ozempic Reuters
July 15, 2026 at 05:46 PMNovo Nordisk launches weekly insulin shot Awiqli in India - Reuters
Novo Nordisk launches weekly insulin shot Awiqli in India Reuters
July 9, 2026 at 06:23 AMSouth African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PMUS FDA approves Sanofi's wearable injector form of blood cancer drug - Reuters
US FDA approves Sanofi's wearable injector form of blood cancer drug Reuters
July 10, 2026 at 05:49 PM